Thus, even though triptolide decreased hypoxia, it also affected the general metabolic pathways in the pancreatic cancer cells leading to decreased IDH1 activity, leading to a decreased synthesis of αKG, which in turn decreased PHD enzyme activity causing an accumulation of HIF-1α in the cells. The gene discussed is IDH1; the disease is familial pancreatic carcinoma.